39 Multidrug-Resistant Gram Negative Bacteria

Friday, March 19, 2010: 12:30 PM-2:00 PM
Grand Hall (Hyatt Regency Atlanta)
Type: Poster
288
The use of gene chip, gene array and multiplex prob array in detection Mycobacterium tuberculosis resistant to rifampin and isoniazid
Yaser Abdolvand, Young Resarcher Club,Azad University-Lahijan,Iran; Masoud Karami, Azad University,Lahijan-Iran; Farzad Tahmasbi, Azad University of Qom-Qom,Iran
289
Performance of the ESwab (ES) Transport System for Recovery of Acinetobacter baumannii (AB)
Jacob Gilad, MD, Tel-Aviv Sourasky Medical Center; David Schwartz, PhD, Tel-Aviv Sourasky Medical Center; Shiri Navon-Venezia, PhD, Tel-Aviv Sourasky Medical Center; Yehuda Carmeli, MD, MPH, Tel Aviv Sourasky Med Ctr
290
Epidemiology of and Mortality among Patients with Pseudomonas (Pseudo) Healthcare-Acquired Infections (HAI)
Aisha Thomas St-Cyr, MD, Medical University of South Carolina; Patrick Mauldin, PhD, Medical University of South Carolina; John Bosso, PharmD, Medical University of South Carolina; Cassandra Salgado, MD, MS, Medical University of South Carolina
291
Epidemic Multiresistant Pseudomonas aeruginosa Causing Persistent Infections and High Mortality in a Hospital with AIDS-Predominant Admissions
Marisa Z. R. Gomes, MD, MS, PhD, Instituto Oswaldo Cruz/FIOCRUZ; Carolina R. Machado, MD, Instituto de Pesquisa Clínica Evandro Chagas; Magda S. Conceição, MD, Instituto de Pesquisa Clínica Evandro Chagas; Helena B. Bernal, MD, Instituto de Pesquisa Clínica Evandro Chagas; Luis E. C. Schettini, MD, Instituto de Pesquisa Clínica Evandro Chagas; Maria Cristina S. Lourenço, MS, Instituto de Pesquisa Clínica Evandro Chagas; Marise D. Asensi, PhD, Instituto Oswaldo Cruz/FIOCRUZ
292
The Prevalence of Fluoroquinolone Resistance Mechanisms in Colonizing Escherichia coli Isolates from Hospitalized Patients
Ebbing Lautenbach, MD, MPH, MSCE, University of Pennsylvania School of Medicine; Joshua Metlay, MD, PhD, University of Pennsylvania; Xiangqun Mao, MD, University of Pennsylvania; Xiaoyan Han, University of Pennsylvania School of Medicine; Neil Fishman, University of Pennsylvania School of Medicine; Warren Bilker, University of Pennsylvania School of Medicine; Pam Tolomeo, University of Pennsylvania School of Medicine; Mary Wheeler, University of Pennsylvania School of Medicine; Irving Nachamkin, University of Pennsylvania School of Medicine
293
Acinetobacter baumannii Transmission: Role of Vancomycin Use as an Intermediate Risk Factor
Gizatchew Ketsela, MD, College of Medicine, University of Florida; Mary Ann Gross, BS, CIC, Shands Hospital at the University of Florida; Charlene Ruse, MT, ASCP, Shands Hospital at the University of Florida; Loretta Fauerbach, MS, CIC, Shands Hospital at the University of Florida; Lennox Archibald, MD, College of Medicine, University of Florida
294
Physicians' Knowledge, Attitudes, and Practices regarding Multidrug-Resistant Gram-Negative Bacilli (MDR-GNB) in Intensive Care Units (ICUs)
Juyan Julia Zhou, MS, MPH, Columbia University; Sameer J. Patel, MD, Columbia University; Scott Weisenberg, MD, DTM&H, Weill Cornell Medical College; NewYork-Presbyterian Hospital; E. Yoko Furuya, MD, MS, Columbia University; NewYork-Presbyterian Hospital; Christine J. Kubin, PharmD, Columbia University; NewYork-Presbyterian Hospital; Luis Alba, BS, Columbia University; Haomiao Jia, PhD, Columbia University; Kyu Rhee, MD, PhD, Weill Cornell Medical College; NewYork-Presbyterian Hospital; Lisa Saiman, MD, MPH, Columbia University; NewYork-Presbyterian Hospital
296
Trends in Ceftazidime and Ciprofloxacin Resistance among U.S. Inpatient Klebsiella pneumoniae and Escherichia coli Isolates, 1999–2006
Marc S. Hoffmann, MD, University of Pennsylvania Department of Medicine; Michael R. Eber, BSE, Resources for the Future; Ramanan Laxminarayan, PhD, MPH, Resources for the Future
297
A Systematic Review of Infection Control Interventions for Extended-Spectrum Beta-Lactamase Producing Enterobacteriaceae (ESBL-E)
Matthew Paul Muller, MD, PhD, FRCPC, St. Michael's Hospital, University of Toronto; Shannon Goddard, MD, University of Toronto
298
ESBL Active Surveillance Culture in patients rehospitalized from other facilities
Hiroyuki Kunishima, MD, PhD, Dept of Infection Control and Laboratory Diagnostics, Tohoku Univ Graduate School; M. Minegishi, Sendai Kosei Hospital; J. Chiba, MT, Sendai Kosei Hospital; S. Nakajima, PhC, Sendai Kosei Hospital; M. Kitagawa, Dept of Infection Control and Laboratory Diagnostics, Tohoku Univ Graduate School; H. Yano, MD, PhD., Tohoku Univ Graduate School, Dept of Clinical Microbiology with Epidemiological Research & Management and Analysis of Infectious; Y. Hirakata, MD, PhD., Tohoku Univ Graduate School, Dept of Clinical Microbiology with Epidemiological Research & Management and Analysis of Infectious; Y. Honda, MD, PhD., Sendai Kosei Hospital; M. Kaku, MD, PhD., Dept of Infection Control and Laboratory Diagnostics, Tohoku Univ Graduate School
299
Changes in susceptibility profile of Gram-negative organisms from bloodstream infection during 2005 to 2009 in a tertiary care hospital
Heli Ferreira Filho, MD, Hospital Heliopolis; Jose Marcos Pereira Costa, MD, Hospital Heliopolis; Marcelo Contardo Moscoso Naveira, MD, Hospital Heliopolis; Odilon Victor Porto Denardin, MD, Hospital Heliopolis; Juvencio Jose Furtado, MD, Hospital Heliopolis; Elisa Maria Beirao, MD, Hospital Heliopolis
300
Risk Factors for Colonization with Carbapenem-Resistant Klebsiella pneumoniae (CRKP) among Past CRKP Carriers in Post Acute Care Facilities (PACF) in Israel
Debby Ben-David, National Center for Infection Control; Samira Masarwa, National Center for Infection Control; Shiri Navon-Venezia, National Center for Infection Control; Gill Smollan, National Center for Infection Control; Hagit Mishali, National Center for Infection Control; Ilan Fridental, National Center for Infection Control; Bina Rubinovitch, National Center for Infection Control; Yehuda Carmeli, National Center for Infection Control; Mitchell J. Schwaber, National Center for Infection Control
301
Risk factors and Outcomes Associated with Blood Stream Infections (BSI) due to Acinetobacter baumannii Resistant to both Carbapenems and Ampicillin/Sulbactam (MDR-AB)
Teena Chopra, MD, Detroit Medical Center,Wayne State University; Jatinder Hothi, MD, Detroit Medical Center,Wayne State University; Dror Marchaim, MD, Detroit Medical Center,Wayne State University; Jessica Slim, MD, Detroit Medical Center,Wayne State University; Khawar Chaudhry, BS, Detroit Medical Center,Wayne State University; Namir Khandker, BS, Detroit Medical Center,Wayne State University; Ryan Tansek, BS, Detroit Medical Center,Wayne State University; Sorabh Dhar, MD, Detroit Medical Center,Wayne State University; Jing Zhao, Pharm, D, Detroit Medical Center,Wayne State University; Jason M. Pogue, Pharm, D, Detroit Medical Center,Wayne State University; David Sengstock, MD, MS, Oakwood Health Care System; Rama Thyagarajan, MD, Oakwood Health Care System; Keith S. Kaye, MD, MPH, Detroit Medical Center,Wayne State University
302
Prevalence of multidrug resistant bacteria and Clostridium difficile in Dutch hospitals, 2007-2009
Titia EM Hopmans, BSc, National Institute for Healthcare Improvement; Tjallie II van der Kooi, MSc, National Institute of Public Health and the Environment; Judith Manniën, MSc, National Institute of Public Health and the Environment; Jan Wille, BSc, National Institute for Healthcare Improvement; Birgit HB van Benthem, MSc, National Institute of Public Health and the Environment
303
Mapping Demographic and Microbiological Correlates in Post GI-Procedure Carbapenemase Producing Klebsiella pneumoniae (KPC) infections in Florida
Dhanashree Kelkar, MD, University of South Florida, College of Medicine, Division of Infectious Diseases and International Medicine; Aliyah Baluch, MD, University of South Florida, College of Medicine, Division of Infectious Diseases and International Medicine; Chaitanya Karlapalem, MBBS, Moffitt Cancer Center; Ramon Sandin, MD, Moffitt Cancer Center; Kay Sams, RN, Moffitt Cancer Center; Roger Sanderson, MA, BSN, Florida Dept of Health; Jose Montero, MD, University of South Florida, College of Medicine, Division of Infectious Diseases and International Medicine; John Greene, MD, University of South Florida, College of Medicine, Division of Infectious Diseases and International Medicine
304
Implementation of the Project of Brazilian Network on Microbial Resistance Monitoring in Health Care Services
Janaína Sallas, National Health Surveillance Agency; Cassio Nascimento Marques, National Health Surveillance Agency; André Rezende, National Health Surveillance Agency; Edzel Ximenes, National health surveillance agency; Julival Ribeiro, PHD, Hospital de Base do Distrito Federal; Heiko Santana, MD, National health surveillance agency; Heder Murari Borba, National health surveillance agency
305
Carbapenemase-producing Klebsiella pneumoniae: description of outcomes at lower Imipenem MICs
Anna Kaltsas, MD, Albert Einstein College of Med/Montefiore Medical Center; Jacques Simkins, MD, Albert Einstein College of Med/Montefiore Medical Center; Mahlet Tadele, MD, Albert Einstein College of Med/Montefiore Medical Center; Brian P. Currie MPH, Albert Einstein College of Med/Montefiore Medical Center
306
Concurrent outbreak and pseudooutbreak of Acinetobacter in multiple intensive care units
Heather C. Yun, MD, San Antonio Military Medical Center; Katrin Mende, PhD, Infectious Disease Clinical Research Program Brooke Army Medical Center; Michele A. Riboul, MS, San Antonio Military Medical Center; Leola R. Taylor, BA, San Antonio Military Medical Center; Yadira Encina, BA, San Antonio Military Medical Center; Daniel R. Dirnberger, MD, San Antonio Military Medical Center; Clinton K. Murray, MD, San Antonio Military Medical Center
307
Clinical Impact of Healthcare-associated Infections Caused by Klebsiella pneumoniae with Decreased Carbapenem Susceptibility
Luci Correa, MD, Hospital Israelita Albert Einstein; Patricia F. Scherer, MD, Hospital Israelita Albert Einstein; Claudia V. Silva, RN, Hospital Israelita Albert Einstein; Thiago ZS Camargo, MD, Hospital Israelita Albert Einstein; Marines DV Martino, MD, Hospital Israelita Albert Einstein; Jacyr Pasternak, MD, Hospital Israelita Albert Einstein; Ana C. Gales, MD, Universidade Federal de São Paulo; Alexandre R. Marra, MD, Hospital Israelita Albert Einstein
308
Control of a Cluster of Multidrug Resistant Acinetobacter baumanii (MDR-Ab) in a Neurosurgical Critical Care Unit (NCCU)
Donna Fellerman, RN, BA, CIC, The Johns Hopkins Hospital; Trish Perl, MD, MSc, The Johns Hopkins Hospital; Gail Biba, BSN, RN, CNRN, The Johns Hopkins Hospital; Pamela Zimmerman, RRT, The Johns Hopkins Hospital; Tracy Ross, BS, MT, (ASCP), The Johns Hopkins Hospital; Karen C. Carroll, MD, The Johns Hopkins Hospital; Lisa L. Maragakis, MD, Johns Hopkins University
309
Carbapenemase-producing Enterobacteriaceae: Identification, Epidemiology and Risk Factors at the Johns Hopkins Hospital
Tal E. Berkowitz, MPH, Johns Hopkins University; Andrew Lee, MHS, Johns Hopkins University; Elaine Fadden, Johns Hopkins Hospital; Warren C. Lee, Johns Hopkins University; Paul D. Stamper, MPH, Johns Hopkins Hospital; Tsigereda Tekle, MT, Johns Hopkins Hospital; Karen C. Carroll, MD, Johns Hopkins Hospital; Lisa L. Maragakis, MD, MPH, Johns Hopkins University
310
Attributable Mortality Due to Carbapenem -Resistant Klebsiella pneumoniae (CRKP) Infection in a Tertiary Care Hospital in Colombia, SA
Ana L. Correa, MD, Hospital Pablo Tobon Uribe; Luz M. Mazo, Hospital Pablo Tobon Uribe; Monica Valderrama, Hospital Pablo Tobon Uribe; Carlos I. Gomez, Hospital Pablo Tobon Uribe; Franco E. Montufar, Hospital Pablo Tobon Uribe; Andrea V. Restrepo, Hospital Pablo Tobon Uribe; Carlos Garces, Hospital Pablo Tobon Uribe; Jaime A. Lopez, Hospital Pablo Tobon Uribe; Monica Trujillo, Hospital Pablo Tobon Uribe; Isabel C. Ramirez, Hospital Pablo Tobon Uribe; John J. Zuleta, Hospital Pablo Tobon Uribe
311
Evaluating imipenem resistance among Pseudomonas aeruginosa infections in the intensive care unit setting
Julie L. Freshwater, BA, MPH, The Ohio State University Medical Center; Yosef M. Khan, MBBS, MPH, The Ohio State University Medical Center; Kelly Kent, BS, The Ohio State University Medical Center; Kurt B. Stevenson, MD, MPH, The Ohio State University Medical Center
312
Control of Acinetobacter baumannii infections: a before after study in a general Intensive Care Unit
Viviana E. Rodriguez, MD, PhD, Hospital Aleman; Pedro Montero, RN, Hospital Aleman; Ricardo A. Durlach, MD, PhD, Hospital Aleman; Liliana Fernandez Canigia, Bq, Hospital Aleman; Cecilia Ezcurra, MD, Hospital Aleman; Diego Torres, RN, Hospital Aleman; Cristina B., Freuler, Md, PhD, Hospital Aleman
313
Reducing Acinetobacter multidrug-Resistant infections in the intensive care unit of a community teaching hospital in Belo Horizonte, Brazil
Silma Maria Cunha Pinheiro, PhD, Federal University of Minas Gerais; Edna Leite, Hospital Universitario Risoleta Tolentino Neves; Alaide Dayrell, RN, Hospital Universitario Risoleta Tolentino Neves; Braulio R.G.M. Couto, MSc, Centro Universitário de Belo Horizonte / UNI-BH
314
A Modified Surveillance Protocol Identifies an Outbreak of Carbapenem Resistant Enterobacteriaceae (CRE) with Reduced Lactose Fermentation
Amy Mathers, MD, University of Virginia Health System; Heather Cox, PharmD, University of Virginia Health System; Joanne Carroll, BS, University of Virginia Health System; Kate Barowski, University of Virginia Health System; Megan Gosseling, MSN, University of Virginia Health System; Keri Hall, MD, Virginia Department of Health; Kevin Hazen, PhD, University of Virginia Health System; Costi D. Sifri, MD, University of Virginia Health System
315
Characterization of Multi-Drug Resistance Among Pseudomonas Isolates in a Tertiary Care Hospital
Gizatchew Ketsela, MD, College of Medicine, University of Florida; Mary Ann Gross, BS, CIC, Shands Hospital at the University of Florida; Charlene Ruse, MT, ASCP, Shands Hospital at the University of Florida; Loretta Fauerbach, MS, CIC, Shands Hospital at the University of Florida; Reuben Ramphal, MD, College of Medicine, University of Florida; Lennox Archibald, MD, College of Medicine, University of Florida